Grassley: Azar Should Use IPI Model As Leverage Against Pharma

By Rachel Cohrs
January 29, 2019 at 6:09 PM
Sen. Chuck Grassley (R-IA), the new Senate Finance Committee chairman, said that HHS Secretary Alex Azar is likely using the administration’s International Price Index model for Medicare Part B to extract concessions from pharmaceutical companies after the committee’s first in a series of planned hearings on prescription drug pricing. A Grassley spokesman declined to elaborate on what the chairman would suggest Azar ask for in return for possibly walking back the advance notice of proposed rulemaking. "My suspicion is that...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.